This information was published on 2025-01-09T15:09:27 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2509991 (IR 1830527) |
| (220) |
15 Aug 2024
|
| (300) |
IL, 04 Mar 2024, 372200
|
| (511) (510) |
Class 5
Pharmaceutical preparations, namely, a drug delivery formulation that enables oral delivery of proteins and peptides; pharmaceutical preparations for use as peptide replacement therapy; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of metabolic conditions; pharmaceutical preparations for the treatment of short bowel syndrome; pharmaceutical preparations for the treatment of stress fractures; drug delivery agents that facilitate the delivery of pharmaceutical preparations. Class 42 Research and development services in the field of pharmaceutical preparations; development of pharmaceutical preparations and medicines; scientific research in the medical and pharmaceutical field, and consultancy and information relating thereto; design and development of new technology for others relating to oral delivery of proteins and peptides, and consultancy and information services relating thereto; research and development in the field of drug delivery systems. Class 45 Licensing of intellectual property; licensing of technology. |
| (540) | N-TAB |
| (550) | Word |
| (730) |
Entera Bio Ltd.
|
Find out more about publications on the About page.